In power distribution systems, three-phase transformer configuration directly impacts system reliability and load management.

Donald Trump’s approval rating hits rock bottom with working class Russian forces near collapse in Kupyansk as Moscow allies concede city lost: Report Press conference makes it clear a lawsuit is ...

The NCAA Transfer Portal doesn't officially open until early January, and many college football players are announcing their intentions to enter it, including an Auburn Tigers edge who may be on ...

Emily Stone, a naturalist at the Cable Natural History Museum, recently published the third installment of her “Natural Connections” series. It explores the relationships found among the plants, ...

Over the past few weeks, three new Broadway shows opened, all with connections to the Boston area. If you're heading to New York City over the holidays, here are some of the shows to check out.

Honkai: Star Rail 3.8 not only marks the debut of a member of the Annihilation Gang, but also has a unique duration. Instead of the usual six weeks, HSR 3.8 will run for over eight weeks. Because of ...

HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences, Inc. (RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory ...

Star Wars: Fate of the Old Republic was the first major announcement for The Game Awards 2025, and it's a doozy. A brand-new single-player action-RPG led by Casey Hudson, director of the original ...

WAYCROSS, Ga. — The Waycross Police Department announced three arrests Wednesday night in connection with the murder of 35-year-old Lawrence Woods. According to the agency, officers responded to ...

ORLANDO, Fla.—With dosing underway in a pivotal phase 3 trial, Star Therapeutics is illuminating the clinical potential of its anti-bleeding antibody VGA039. In a phase 1/2 trial in von Willebrand ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for bleeding disorders and other ...